Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis (original) (raw)
Ferlay J, F Bray, P Pisani and D M Parkin . GOBOCAB 2000 Cancer Incidence, Mortality and Prevalence Worldwide,. Lyon: IARC Scienctific Publications, IARC Press, 2001
Parkin D, P Pisani and J Ferlay . Global cancer statistics. CA Cancer J. Clin., 1999; 49:33–64. ArticleCAS Google Scholar
Cancer Incidence and Mortality in China, 1993–1997 (Selected Cities and Counties). Beijing: China Publishing House of Medical Sciences and Technologies, 1998
Feitelson M A, B Sun, N L Satiroglu Tufan, J Liu, J Pan and Z Lian . Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21(16):2593–604. ArticleCASPubMed Google Scholar
Kim J W and X W Wang . Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis 2003; 24(3):363–9. ArticleCASPubMed Google Scholar
Wang X W, S P Hussain, T I Huo, et al. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 2002; 181–182:43–7. ArticleCASPubMed Google Scholar
Baylin S and T H Bestor . Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 2002; 1(4):299–305. ArticleCASPubMed Google Scholar
Esteller M . Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003; 4(6):351–8. ArticleCASPubMed Google Scholar
Esteller M and J G Herman . Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002; 196(1):1–7. ArticleCASPubMed Google Scholar
Jones P A and D Takai . The role of DNA methylation in mammalian epigenetics. Science 2001; 293(5532):1068–70. ArticleCASPubMed Google Scholar
Jaenisch R and A Bird . Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 Suppl:245–54. ArticleCASPubMed Google Scholar
Jones P A . Epigenetics in carcinogenesis and cancer prevention. Ann N Y Acad Sci 2003; 983:213–9. ArticleCASPubMed Google Scholar
Geiman T M and K D Robertson . Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together? J Cell Biochem 2002; 87(2):117–25. ArticleCASPubMed Google Scholar
Feninberg A . Cancer epigenetics takes center stage. Proc. Natl. Acad. Sci. U S.A. 2001; 98(2):392–4. Article Google Scholar
Eden A, F Gaudet, A Waghmare and R Jaenisch . Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300(5618):455. ArticleCASPubMed Google Scholar
Gaudet F, J G Hodgson, A Eden, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300(5618):489–92. ArticleCASPubMed Google Scholar
Chen R Z, U Pettersson, C Beard, L Jackson-Grusby and R Jaenisch . DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395(6697):89–93. ArticleCASPubMed Google Scholar
Esteller M, M F Fraga, M Guo, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 2001; 10(26):3001–7. ArticleCASPubMed Google Scholar
Zochbauer-Muller S, K M Fong, A K Virmani, J Geradts, A F Gazdar and J D Minna . Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001; 61(1):249–55. CASPubMed Google Scholar
Rosas S L, W Koch, M G da Costa Carvalho, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001; 61(3):939–42. CASPubMed Google Scholar
Foster S A, D J Wong, M T Barrett and D A Galloway . Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 1998; 18(4):1793–801. ArticleCASPubMedPubMed Central Google Scholar
Cui H, P Onyango, S Brandenburg, Y Wu, C L Hsieh and A P Feinberg . Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002; 62(22):6442–6. CASPubMed Google Scholar
Cho B, H Lee, S Jeong, et al. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem Biophys Res Commun 2003; 307(1):52–63. ArticleCASPubMed Google Scholar
Hattori M, H Sakamoto, K Satoh and T Yamamoto . DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 2001; 169(2):155–64. ArticleCASPubMed Google Scholar
Hoare S F, L A Bryce, G B Wisman, et al. Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res 2001; 61(1):27–32. CASPubMed Google Scholar
Toyota M, N Ahuja, M Ohe-Toyota, J G Herman, S B Baylin and J P Issa . CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96(15):8681–6. ArticleCASPubMedPubMed Central Google Scholar
Yu J, M Ni, J Xu, et al. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002; 2(1):29. ArticlePubMedPubMed Central Google Scholar
Liver Cancer Study Group of Japan. TNM classification for hepatocellular carcinoma by Liver Cancer Study group. World J Surg 1989; 13:212.
Miller A J . Subset Selection in Regression. New York Champman and Hall 1990.
Liu Q, Wang, W, & eds. Liver Cancer. Beijing: People's Medical Publishing House, 2000
Mou D C, S L Cai, J R Peng, et al. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 2002; 86(1):110–6. ArticleCASPubMedPubMed Central Google Scholar
Yin H and K Blanchard . DNA methylation represses the expression of the human erythopoietin gene by two diffferent mechanisms. Blood 2000; 95(1):111–9. ArticleCASPubMed Google Scholar
Sauter P and P Matthias . Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA. Mol Cell Biol 1998; 18(12):7397–409. ArticleCASPubMedPubMed Central Google Scholar
Iwamoto S, D A Withers, K Handa and S Hakomori . Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. Glycoconj J 1999; 16(10):659–66. ArticleCASPubMed Google Scholar
Chen B, P Dias, J J Jenkins, 3rd, V H Savell and D M Parham . Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Am J Pathol 1998; 152(4):1071–9. CASPubMedPubMed Central Google Scholar
Hutchins A S, A C Mullen, H W Lee, et al. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 2002; 10(1):81–91. ArticleCASPubMed Google Scholar
Reeben M, S Myohanen, M Saarma and H Prydz . Sequencing of the rat light neurofilament promoter reveals differences in methylation between expressing and non-expressing cell lines, but not tissues. Gene 1995; 157(1-2):325–9. ArticleCASPubMed Google Scholar
Kibel A S, M Christopher, D A Faith, G S Bova, P J Goodfellow and W B Isaacs . Methylation and mutational analysis of p27(kip1) in prostate carcinoma. Prostate 2001; 48(4):248–53. ArticleCASPubMed Google Scholar
Li Y, H Nagai, T Ohno, et al. Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood 2002; 100(7):2572–7. ArticleCASPubMed Google Scholar
Watanabe T, H Huang, M Nakamura, et al. Methylation of the p73 gene in gliomas. Acta Neuropathol (Berl) 2002; 104(4):357–62. CAS Google Scholar
Laux D E, E M Curran, W V Welshons, D B Lubahn and T H Huang . Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas. Breast Cancer Res Treat 1999; 56(1):35–43. ArticleCASPubMed Google Scholar
Wang S, T Hashemi, S Fried, A L Clemmons and B E Hawes . Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 1998; 37(19):6711–7. ArticleCASPubMed Google Scholar
Usmani B A, R Shen, M Janeczko, et al. Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Clin Cancer Res 2000; 6(5):1664–70. CASPubMed Google Scholar
Venkataraman G M, M Yatin, R Marcinek and K B Ain . Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status. J Clin Endocrinol Metab 1999; 84(7):2449–57. CASPubMed Google Scholar
Cui J, L R Rohr, G Swanson, V O Speights, T Maxwell and A R Brothman . Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 2001; 46(3):249–56. ArticleCASPubMed Google Scholar
Toyota M, C Ho, N Ahuja, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999; 59(10):2307–12. CASPubMed Google Scholar
Sasaki M, Y Tanaka, G Perinchery, et al. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst 2002; 94(5):384–90. ArticleCASPubMed Google Scholar
Muller C, C Readhead, S Diederichs, et al. Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent. Mol Cell Biol 2000; 20(9):3316–29. ArticleCASPubMedPubMed Central Google Scholar
Rachmilewitz E A . The role of methylation in CML. Przegl Lek 2000; 57 Suppl 1:25–6. Google Scholar
Habuchi T, M Luscombe, P A Elder and M A Knowles . Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics 1998; 48(3):277–88. ArticleCASPubMed Google Scholar
Ghoshal K, S Majumder, Z Li, X Dong and S T Jacob . Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation. J Biol Chem 2000; 275(1):539–47. ArticleCASPubMed Google Scholar
Yamanaka M, M Watanabe, Y Yamada, et al. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 2003; 106(3):382–7. ArticleCASPubMed Google Scholar
Tavian D, G De Petro, A Pitozzi, N Portolani, S M Giulini and S Barlati . Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. Histol Histopathol 2002; 17(4):1113–9. CASPubMed Google Scholar
Dong S, J C Pang, J Hu, L F Zhou and H K Ng . Transcriptional inactivation of TP73 expression in oligodendroglial tumors. Int J Cancer 2002; 98(3):370–5. ArticleCASPubMed Google Scholar
Loiseau H, J Arsaut and J Demotes-Mainard . p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas. Neurosci Lett 1999; 263(2-3):173–6. ArticleCASPubMed Google Scholar
Satoh Y, T Nakagawachi, H Nakadate, et al. Significant Reduction of WT1 Gene Expression, Possibly Due to Epigenetic Alteration in Wilms' Tumor. J Biochem (Tokyo) 2003; 133(3):303–8. ArticleCAS Google Scholar
Tomita Y, V Bilim, N Hara, T Kasahara and K Takahashi . Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells. Int J Cancer 2003; 104(4):400–8. ArticleCASPubMed Google Scholar
Detjen K M, D Murphy, M Welzel, K Farwig, B Wiedenmann and S Rosewicz . Downregulation of p21(waf/cip-1) mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-gamma. Exp Cell Res 2003; 282(2):78–89. ArticleCASPubMed Google Scholar
Lu R, W C Au, W S Yeow, N Hageman and P M Pitha . Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hyperme-thylation. J Biol Chem 2000; 275(41):31805–12. CASPubMed Google Scholar
Ehrlich M . DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21(35):5400–13. ArticleCASPubMed Google Scholar
Su Q and P Bannasch . Relevance of hepatic preneoplasia for human hepatocarcinogenesis. Toxicol Pathol 2003; 31(1):126–33. ArticlePubMed Google Scholar
Kopp-Schneider A . Biostatistical evaluation of focal hepatic preneoplasia. Toxicol Pathol 2003; 31(1):121–5. ArticlePubMed Google Scholar
Baylin S B and J G Herman . DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16(4):168–74. ArticleCASPubMed Google Scholar
Bestor T H . Unanswered questions about the role of promoter methylation in carcinogenesis. Ann N Y Acad Sci 2003; 983:22–7. ArticleCASPubMed Google Scholar